This course is designed to provide a comprehensive understanding of paediatric medical cannabis, focusing particularly on the implications of TGA category changes and their direct impact on clinical practices and outcomes for children. Led by a team of esteemed experts, this course navigates through various crucial aspects of paediatric medical cannabis use, offering both theoretical knowledge and practical insights derived from real-world experiences.

What is Cannabis Medicine? This module delves into the differences between medicinal and illicit use of cannabis, emphasising that medicinal cannabis is controlled for purity and labelled for cannabinoid content, offering safer and consistent treatments. Dr. Teh advocates the transition from unregulated cannabis to the medical market for quality, safety, and professional medical guidance. The module aims to educate on cannabis's therapeutic applications and promote a deeper understanding of its healing role.

Explore how cannabinoids can be used to manage chronic pain. This module dives into clinical considerations, along with personalised dosing strategies tailored to individual patients through case studies.

This module dives into how cannabinoids interact with the body's pain signaling system to reduce chronic pain. It explores how these molecules work in both the central nervous system (brain and spinal cord) and the peripheral nervous system (throughout the body) to achieve pain relief.

This module explores how vaporised inhaled cannabis can effectively manage symptom flare-ups. It emphasises balancing immediate relief with long-term treatment plans. Additionally, it educates patients and caregivers on both safe use practices and relevant legal considerations.

This module examines the safety of medicinal cannabis, including potential side effects and interactions with other medications. While it emphasises the generally well-tolerated nature of medicinal cannabis, it also stresses the importance of careful monitoring by a healthcare professional.

Dr. Teh's module explores how cannabis medicine works. Inhalation offers fast but short effects, while oral/sublingual routes have slower onset but last longer. Rectal suppositories have unclear benefits. Topical applications target skin issues without psychoactive effects. Other routes like patches and sprays may be useful for specific needs.

Dr. Dustin Sulak's "Combining Cannabinoids for Treatment Success" module explores the complexities of cannabinoid therapy. It highlights the importance of recognising cannabis chemotypes and their acidic and neutral forms, such as THCA and THC. The course focuses on the synergistic and antagonistic effects of cannabinoid combinations, supported by clinical data. Dr. Sulak advocates for customised treatment plans based on individual patient responses and discusses how cannabinoids interact in the body. He offers case studies, research, and practical strategies for healthcare providers to develop adaptable cannabis treatment regimens, emphasising full-spectrum chemotypes and the integration of cannabinoids like CBG and THCV.

Dr. Teh's module explores personalised cannabis medicine. Dosing is adjusted based on patient response and experience, due to limited clinical data. He emphasises a whole-plant approach and patient-centred care. Safety is stressed, with a "start low, go slow" motto. Cannabis is seen as a safe treatment with patient empowerment encouraged.

This module equips medical professionals to guide self-medicating cannabis users into the regulated medical system. It emphasises understanding a patient's cannabis history and the science of the endocannabinoid system to craft personalised plans, minimising harm and optimising patient outcomes.

Dr. Teh's module explores whole plant cannabis vs. isolates for childhood epilepsy. It examines a UK study suggesting whole plant options may be more effective, highlighting the entourage effect. The module finds cannabis well-tolerated with mild side effects compared to traditional medications.

This module explores CBD's benefits in medicinal cannabis, focusing on its role in reducing THC side effects and its potential for treating anxiety and inflammation. Dr. Teh discusses proper dosing, the entourage effect, and the importance of transitioning patients from unregulated cannabis to safe, CBD-containing medical regimens.

This module explores the endocannabinoid system (ECS), a regulatory system found in vertebrates. The ECS uses endocannabinoids and receptors to maintain balance in various functions, from stress to digestion. Unlike typical systems, the ECS creates chemicals on-demand to target specific areas. The module explores the ECS's role in the nervous system and the potential of cannabis compounds to influence it for therapeutic purposes.

This module explores the full potential of cannabis, diving into minor cannabinoids, terpenes, and the entourage effect. Led by Dr. John Teh, it goes beyond THC and CBD to unlock the synergy of the entire plant for better health.

This course by Dr. Teh explores medicinal cannabis basics: THC (psychoactive & therapeutic) and CBD (non-psychoactive & balancing). It explains how they interact with the body's endocannabinoid system and the potential benefits of full-spectrum extracts.

Lisa Varley's module explains the MSL role in medicinal cannabis. It covers traditional MSL duties, but emphasises market knowledge, education, regulations, and a customer-centric approach. It highlights the importance of sharing anecdotal evidence due to limited clinical trials.

This module explores the benefits and uses of hemp, a plant with a long history. Once a common crop, hemp is now differentiated from marijuana due to low THC content. Hemp is environmentally friendly, absorbing carbon dioxide and offering sustainable materials like bioplastics and hempcrete. The module concludes by recommending hemp for a variety of uses to benefit people and the planet.

This module explores using medicinal cannabis (esp. CBD) to treat anxiety, insomnia, and depression. Dr. Teh covers the potential for CBD to replace opiates, its role in the endocannabinoid system, and how to prescribe cannabis for these conditions.

Dr. Herzberg's module explains legalities of prescribing medicinal cannabis in Australia. It covers TGA regulations, access schemes, and prescriber responsibilities, focusing on unapproved products and patient safety.

This module explores pros and cons of inhaled vs. oral cannabis medicine, safety considerations, and potential benefits for chronic pain. It emphasises non-combustion methods and avoiding drug interactions.

This module criticises roadside drug testing in Australia for unfairly targeting medicinal cannabis users. It argues the tests don't improve safety and disproportionately impact vulnerable groups. Legal experts, medical professionals, and affected individuals advocate for reform based on science and social justice.

This module dives into cannabis chemovars, emphasising their importance in medical treatment. It debunks indica/sativa myths, highlighting terpenes and unique chemical profiles for effective care. Focusing on genetics and patient needs, the module explores breeding, terpenes' effects, and personalised chemovar selection for optimal outcomes.

The module examines the endocannabinoid system (ECS), highlighting its essential role in human homeostasis and detailing the functions of primary endocannabinoids and the CB1 and CB2 receptors that operate system-wide. It emphasizes the relative safety of cannabis medicines, particularly their low risk of overdose and respiratory depression. Additionally, the material delves into the immune modulating functions of CB2 receptors and the entourage effect, where the interplay between cannabinoids and terpenes finely tunes bodily functions. A special focus is given to Clinical Endocannabinoid Deficiency and its suspected ties to various diseases. Treatment strategies to boost ECS activity, including lifestyle changes and phytocannabinoid use, are discussed, showcasing the broad therapeutic potential of cannabis in healthcare.

This module covers the essentials of THC and CBD—the two primary cannabinoids in the cannabis plant. Emphasising their therapeutic potential and interactions with the body's endocannabinoid system, the course also notes the importance of the entourage effect, where cannabinoids and terpenes in whole plant extracts may offer enhanced benefits compared to isolated compounds.

The module addresses the differences between indica and sativa strains, emphasising the need for personalised treatment based on specific cannabinoid and terpene profiles. This module underscores the scientific basis for the therapeutic use of cannabis, advocating for a nuanced understanding of its components for improved patient care.

This module explores the historical and medicinal use of cannabis across various cultures, tracing its journey from ancient times to its role as a medicinal and trade good. We'll analyse the decline in cannabis use during the 20th century due to medical, economic, and legal factors. The impact of the Marijuana Tax Act and anti-cannabis propaganda on modern perception will also be examined. Finally, the module advocates for a reassessment of cannabis's medicinal value based on historical context.

What is Cannabis Medicine? This module delves into the differences between medicinal and illicit use of cannabis, emphasising that medicinal cannabis is controlled for purity and labelled for cannabinoid content, offering safer and consistent treatments. Dr. Teh advocates the transition from unregulated cannabis to the medical market for quality, safety, and professional medical guidance. The module aims to educate on cannabis's therapeutic applications and promote a deeper understanding of its healing role.